leukocytoclastic vasculitis; hypersensitivity vasculitis; trisymptome
Jump to navigation
Jump to search
Etiology
- autoimmune disease
- recent viral infection
- malignancy - lymphoproliferative disorders
- drug adverse effect
- systemic vasculitis
- idiopathic (40%)[1]
Clinical manifestations
- palpable purpura
- cutaneous vesicles, pustules, maculopapular lesions, urticaria
- occurs within 2 weeks of exposure to offending agent
- generally resolves when the offending agent is removed[1]
Laboratory
Differential diagnosis
Management
- generally self-limited
- withdrawal of offending agent
- glucocorticoids
- see acute leukocytoclastic vasculitis (Henoch-Schonlein purpura) or specific etiology
More general terms
More specific terms
- acute leukocytoclastic vasculitis (Henoch-Schonlein purpura; IgA vasculitis)
- chronic leukocytoclastic vasculitis (Gougerot-Ruiter type)
- cutaneous leukocytoclastic vasculitis
- urticarial vasculitis
Additional terms
- cryoglobulinemia (cryoglobulinemic vasculitis)
- leukocytoclasis
- serum sickness; serum sickness-like reaction
References
- ↑ 1.0 1.1 1.2 Medical Knowledge Self Assessment Program (MKSAP) 14, 16, 17, 18, 19. American College of Physicians, Philadelphia 2006, 2012, 2015, 2018. 2022.
- ↑ Eastham ABW, Diamond HS (images) Medscape: Leukocytoclastic Vasculitis. http://emedicine.medscape.com/article/333891-overview
- ↑ Kroshinsky D Adverse cutaneous reactions to medications Clin Dermatol. 2020 Nov-Dec;38(6):605-606 PMID: https://www.ncbi.nlm.nih.gov/pubmed/33341194